Biomarkers in Cancer Staging, Prognosis and Treatment Selection

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Nature Reviews. Cancer

• Publication date

  2005-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nrc1739PMID 16239904
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reconstruction of cellular signalling networks and analysis of their properties

  2005cited by this paper
• DNA methylation and cancer therapy: new developments and expectations

  2005cited by this paper
• EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.

  2005cited by this paper
• Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.

  2004cited by this paper
• Dissecting the metastatic cascade

  2004cited by this paper
• Ribonucleotide Reductase Messenger RNA Expression and Survival in Gemcitabine/Cisplatin-Treated Advanced Non-Small Cell Lung Cancer Patients

  2004cited by this paper
• Circulating Tumor Cells in Patients with Breast Cancer Dormancy

  2004cited by this paper
• Anticancer drugs: To the rescue?

  2004cited by this paper
• Retrospective analysis of the predictive factors associated with the response and survival benefit of gefitinib in patients with advanced non-small-cell lung cancer.

  2004cited by this paper
• Can computer-aided detection with double reading of screening mammograms help decrease the false-negative rate? Initial experience.

  2004cited by this paper
• Feasibility of 99mTc-annexin V for repetitive detection of apoptotic tumor response to chemotherapy: an experimental study using a rat tumor model.

  2004cited by this paper
• Enumeration of Circulating Tumor Cells in the Blood of Breast Cancer Patients After Filtration Enrichment: Correlation with Disease Stage

  2004cited by this paper
• Rules of evidence for cancer molecular-marker discovery and validation

  2004cited by this paper
• A review of depsipeptide and other histone deacetylase inhibitors in clinical trials.

  2004cited by this paper
• T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistance.

  2004cited by this paper
• High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines

  2004cited by this paper
• Preferential response of cancer cells to zebularine.

  2004cited by this paper
• Pulmonary nodules at chest CT: effect of computer-aided diagnosis on radiologists' detection performance.

  2004cited by this paper
• DNA-microarray analysis of brain cancer: molecular classification for therapy

  2004cited by this paper
• EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

  2004cited by this paper
• Bone marrow micrometastases and circulating tumor cells: current aspects and future perspectives

  2004cited by this paper
• The use and development of germline polymorphisms in clinical oncology.

  2004cited by this paper
• Gene expression profiles of human breast cancer progression

  2003cited by this paper
• Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling.

  2003cited by this paper
• 18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma.

  2003cited by this paper
• Breast cancer classification and prognosis based on gene expression profiles from a population-based study

  2003cited by this paper
• Nanoparticle-Based Bio-Bar Codes for the Ultrasensitive Detection of Proteins

  2003cited by this paper
• Genome-wide genetic characterization of bladder cancer: a comparison of high-density single-nucleotide polymorphism arrays and PCR-based microsatellite analysis.

  2003cited by this paper
• Quantum Dots Get Wet

  2003cited by this paper
• Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma.

  2003cited by this paper
• The genetics and genomics of cancer

  2003cited by this paper
• Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system.

  2003cited by this paper
• High frequency of DAP-kinase gene promoter methylation in colorectal cancer specimens and its identification in serum.

  2003cited by this paper
• Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots

  2003cited by this paper
• A molecular signature of metastasis in primary solid tumors

  2003cited by this paper
• Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients.

  2003cited by this paper
• Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays

  2003cited by this paper
• Lab-on-a-chip for drug development.

  2003cited by this paper
• A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment

  2003cited by this paper
• Self-assembled nanoscale biosensors based on quantum dot FRET donors

  2003cited by this paper
• Molecular targeting with radionuclides: state of the science.

  2003cited by this paper
• Early detection: Proteomic applications for the early detection of cancer

  2003cited by this paper
• Microarray data—the US FDA, industry and academia

  2003cited by this paper
• Utility of tumor markers in determining resectability of pancreatic cancer.

  2003cited by this paper
• Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer.

  2003cited by this paper
• Clinical role of FDG PET in evaluation of cancer patients.

  2003cited by this paper
• TNM: evolution and relation to other prognostic factors.

  2003cited by this paper
• Molecular detection of p16 promoter methylation in the serum of recurrent colorectal cancer patients

  2003cited by this paper
• Cancer biomarker validation: standards and process: roles for the National Institute of Standards and Technology (NIST).

  2003cited by this paper
• Gene-expression profiling in human cutaneous melanoma

  2003cited by this paper
• Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576.

  2003cited by this paper
• Polymorphisms in the CYP1A1 gene are associated with prostate cancer risk

  2003cited by this paper
• Molecular Differentiation of High- and Moderate-Grade Human Prostate Cancer by cDNA Microarray Analysis

  2003cited by this paper
• Ovarian cancer: the clinical role of US, CT, and MRI

  2003cited by this paper
• Nanoscale quantum dots hold promise for cancer applications.

  2003cited by this paper
• Pretherapy quantitative measurement of circulating Epstein–Barr virus DNA is predictive of posttherapy distant failure in patients with early‐stage nasopharyngeal carcinoma of undifferentiated type

  2003cited by this paper
• Radiopharmaceuticals for targeting the angiogenesis marker alpha(v)beta(3).

  2003cited by this paper
• Cancer Biomarker Validation: Standards and Process

  2003cited by this paper
• Radiopharmaceuticals for targeting the angiogenesis marker αvβ3

  2003cited by this paper
• The Human Plasma Proteome: History, Character, and Diagnostic Prospects

  2003cited by this paper
• American Chemical Society meeting. Nanomaterials show signs of toxicity.

  2003cited by this paper
• American Chemical Society meeting. Tiny transistors scout for cancer.

  2003cited by this paper
• [Serial analysis of gene expression].

  2002cited by this paper
• Clinical proteomics: translating benchside promise into bedside reality

  2002cited by this paper
• Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer.

  2002cited by this paper
• 2D Differential In-gel Electrophoresis for the Identification of Esophageal Scans Cell Cancer-specific Protein Markers*

  2002cited by this paper
• A controlled trial of a human papillomavirus type 16 vaccine.

  2002cited by this paper
• Revision of the American Joint Committee on Cancer staging system for breast cancer.

  2002cited by this paper
• Proteomics of human breast ductal carcinoma in situ.

  2002cited by this paper
• Computer-Aided Detection and Diagnosis at the Start of the Third Millennium

  2002cited by this paper
• Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer

  2002cited by this paper
• Issues and barriers to development of clinically useful tumor markers: a development pathway proposal.

  2002cited by this paper
• Transformation of follicular lymphoma to diffuse large-cell lymphoma: Alternative patterns with increased or decreased expression of c-myc and its regulated genes

  2002cited by this paper
• Haplotype and linkage disequilibrium architecture for human cancer-associated genes.

  2002cited by this paper
• The promise of biomarkers in cancer screening and detection.

  2002cited by this paper
• Genetic polymorphisms of XRCC1 and risk of gastric cancer.

  2002cited by this paper
• p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity.

  2002cited by this paper
• Assessing the use of p16(INK4a) promoter gene methylation in serum for detection of bladder cancer.

  2002cited by this paper
• A gene-expression signature as a predictor of survival in breast cancer.

  2002cited by this paper
• Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon

  2002cited by this paper
• Emerging molecular markers of cancer

  2002cited by this paper
• Regulatory issues in tumor marker development.

  2002cited by this paper
• Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer

  2002cited by this paper
• 'Omic' and hypothesis-driven research in the molecular pharmacology of cancer.

  2002cited by this paper
• Gene expression profiling predicts clinical outcome of breast cancer

  2002cited by this paper
• The Human Plasma Proteome

  2002cited by this paper
• Translating the Histone Code

  2001cited by this paper
• A gene hypermethylation profile of human cancer.

  2001cited by this paper
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

  2001cited by this paper
• Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients.

  2001cited by this paper
• Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer.

  2001cited by this paper
• Mitochondrial genome instability in human cancers.

  2001cited by this paper
• Pharmacogenetics and cancer therapy

  2001cited by this paper
• Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.

  2001cited by this paper
• Haplotype tagging for the identification of common disease genes

  2001cited by this paper
• Tumor markers in breast cancer monitoring should be scheduled according to initial stage and follow-up time: a prospective study on 859 patients.

  2001cited by this paper
• Phases of biomarker development for early detection of cancer.

  2001cited by this paper
• Diversity of gene expression in adenocarcinoma of the lung

  2001cited by this paper
• Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy.

  2001cited by this paper
• Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma.

  2001cited by this paper

• HMHGT: Hierarchical Multi-Scale Hypergraph Representation for Histopathology Whole Slide Images

  2026cites this paper
• MRI, PET/CT and PET/MRI Fusion in the Assessment of Lymph Node Metastases in Head and Neck Cancer

  2026cites this paper
• Porphyrinic Metal-Organic Frameworks with Longitudinal Pt Deposition Referenced as Opto/Catalytic Adjuvants for Dual-Path Glycoprotein Assay.

  2026cites this paper
• Rapid and sensitive detection of RNA biomarkers using morpholino-functionalized organic electrochemical transistor

  2026cites this paper
• A portable biomimetic vortex tangential flow filtration (VTFF) system for efficient isolation and purification of extracellular vesicles

  2026cites this paper
• Pre-treatment peripheral absolute monocyte count predicts metastatic progression and survival outcomes in treatment-naive non-metastatic nasopharyngeal carcinoma.

  2026cites this paper
• Glycan and glycoprotein signatures in tumor-induced liver alterations in a murine breast cancer model

  2026cites this paper
• Natural Cell-Inspired Integration of Redox Reactant Molecules in Hierarchical MOFs Harvested for Reaction Pathway-Regulated Glycoprotein Assay.

  2026cites this paper
• Conductive Metal-Organic Frameworks Based Sensors for Disease Diagnosis

  2026cites this paper
• A Comprehensive Analysis of Epoxide Hydrolase 2 (EPHX2) in Pan‐Cancer

  2025cites this paper
• Identifying Cancer Stage-Related Biomarkers for Lung Adenocarcinoma by Integrating Both Node and Edge Features

  2025cites this paper
• The Role of the Hexosamine-Sialic Acid Metabolic Pathway Mediated by GFPT1/NANS in c-Myc-Driven Hepatocellular Carcinoma

  2025cites this paper
• From detection to drug delivery: innovations in cancer biosensors from concept to clinical impact

  2025cites this paper
• Assessing lung cancer progression and survival with infrared spectroscopy of blood serum

  2025cites this paper
• Dual-Mode Tumor Diagnosis and Guided Precise Photodynamic Therapy Based on MicroRNA Fluorescence Signal Amplification and Magnetic Resonance Imaging.

  2025cites this paper
• Digital Twin Technology In Radiology.

  2025cites this paper
• NFATc4 Promotes Lung Adenocarcinoma Progression via the CCNB1/CDK1 Pathway and Is a Potential Prognostic Biomarker

  2025cites this paper
• Biomarkers for the Diagnosis of Perinatal Mood and Anxiety Disorders: Existing Landscapes and Emerging Frontiers.

  2025cites this paper
• Nanoarchitectonic optimization of film thickness and immobilization time of gold nanourchins for directional, label-free immunosensing of cancer biomarkers in blood serum

  2025cites this paper
• Golden eyes on pollutants: colorimetric detection of emerging contaminants with AuNPs

  2025cites this paper
• Trends and Hotspots in Nanomedicine Applications for Pain: A Bibliometric Analysis from 1999 to 2024

  2025cites this paper
• Polyethyleneimine‐Assisted Boronic Acid‐Modified Magnetic Multi‐Walled Carbon Nanotubes for the Isolation and Concentration of Cis‐Diol‐Containing Biomolecules

  2025cites this paper
• Opto/Catalytic Metal-Organic Framework Adjuvant-Empowered Acidolytic Nanozymes Amplified for Bimodal Glycoprotein Assay.

  2025cites this paper
• Fluorescent Nanoprobe Based on 2D Al2O3 Nanosheets for Clioquinol Detection

  2025cites this paper
• Optimizing Colorectal Cancer Treatment with Unconventional Therapies: A Data-Driven AI Approach for Comprehensive Image-Based Evaluation and Treatment Ranking

  2025cites this paper
• SERPINA1 methylation as a novel diagnostic marker for early-stage papillary thyroid carcinoma via MAPK6-AKT/mTOR pathway

  2025cites this paper
• Generative AI - Assisted Adaptive Cancer Therapy

  2025cites this paper
• Pathways to precision medicine in cervical cancer: a comprehensive review of small molecule inhibitors, biomarkers and computational approaches

  2025cites this paper
• EfficientMIL: Efficient Linear-Complexity MIL Method for WSI Classification

  2025cites this paper
• Optimal Value of Mutant KRAS Circulating Tumor DNA for Predicting Prognosis and Monitoring in Patients with Pancreatic Adenocarcinoma: A Prospective Multicenter Cohort Study.

  2025cites this paper
• MARPLE: A Proximity‐Triggered CRISPR‐Cas13 Platform for Ultrasensitive Antibody Detection

  2025cites this paper
• Advances in occult cancer screening for patients with unprovoked venous thromboembolism: A narrative review of epidemiology, risk, and clinical strategies

  2025influential citation
• Diagnostic Use of the Combination of CA72‐4 and Tumor Volume in Mucinous Ovarian Tumors

  2025cites this paper
• Microfluidic Nanosensor for Label-Free Multiplexed Detection of Breast Cancer Biomarkers via Surface-Enhanced Reflective FTIR Spectroscopy Using Thin Gold Films and Antibody-Oriented Gold Nanourchin: Feasibility Study

  2025cites this paper
• Detection of pre-transition phases during biological development using single-sample network entropy (SNE)

  2025cites this paper
• Identification and validation of an immune-related programmed cell death signature for predicting prognosis and immunotherapy in large-scale multicenter cohorts for lung adenocarcinoma

  2025cites this paper
• A facile and sensitive protein immune polyacrylamide gel electrophoresis with online fluorescent imaging.

  2025cites this paper
• Multi-omics Analysis of NUDT19 Across Cancer Types and Its Functional Role in Leukemia

  2025cites this paper
• DSCC1 Identified as Promising Tumor Biomarker and Potential Therapeutic Target Through Comprehensive Multi-omics Analysis and Experimental Validation.

  2025cites this paper
• D-band modulated bifunctional PdSn alloy nanozymes for advanced dual-mode biosensing

  2025cites this paper
• Synergistic effect of ternary nanoparticles ag@Zn-In2S3-(3-MPA): enhancement of catalyst electrocatalytic activity and luminophore electrochemiluminescence efficiency.

  2025cites this paper
• A CRISPR/Cas12a-powered liquid crystal aptasensor for point-of-care detection of prostate-specific antigen for early-stage cancer diagnosis.

  2025cites this paper
• Enhancing Zero-Shot Brain Tumor Subtype Classification via Fine-Grained Patch-Text Alignment

  2025cites this paper
• Metabolomic machine learning predictor for diagnosis and prognosis of gastric cancer

  2024cites this paper
• A Raman topography imaging method toward assisting surgical tumor resection

  2024cites this paper
• Chitosan lecithin nanocomposite based electrochemical biosensor for glycine detection in biological matrices.

  2024cites this paper
• Lectin-Mimicking Aptamer as a Generic Glycan Receptor for Sensitive Detection of Glycoproteins Associated with Cancer

  2024cites this paper
• Treatment-Related Lymphopenia is Possibly a Marker of Good Prognosis in Nasopharyngeal Carcinoma: a Propensity-Score Matching Analysis

  2024cites this paper
• Textural Precursor Compositions Harvested for Independent Signal Generators: Scaling Micron-Sized Flower-Like Metal-Organic Frameworks as Amplifying Units for Dual-Mode Glycoprotein Assay.

  2024cites this paper
• Bioinspired Spatial Compartment of Substrate Molecules and Catalytic Counting Entities in Hierarchical MOFs Initiated for a Dual-Mode Glycoprotein Assay.

  2024cites this paper
• Cancer treatment approaches within the frame of hyperthermia, drug delivery systems, and biosensors: concepts and future potentials

  2024cites this paper
• Machine Learning-based Prognostic Subgrouping of Glioblastoma: A Multi-center Study.

  2024cites this paper
• Fabrication of and characterization of directional antibody-conjugated gold nanourchin colloid and effect of laser polarization on SERS detection of breast cancer biomarker in serum

  2024cites this paper
• Surface-Enhanced Raman Spectroscopy at the Interface between Drug Discovery and Personalized Medicine

  2024cites this paper
• Predicting the Recurrence of Ovarian Cancer Based on Machine Learning

  2024cites this paper
• Overview of Cancer and Treatment Challenges: Harnessing the Anti-cancer Potential of Jasminum Sambac and its Nanoparticle Formulations

  2024cites this paper
• Liquid Biopsy and its significance on the Early Detection of Breast Cancer

  2024cites this paper
• Side effects of prostate cancer therapies and potential management

  2024cites this paper
• Snuffy: Efficient Whole Slide Image Classifier

  2024cites this paper
• Evolution of artificial intelligence as a modern technology in advanced cancer therapy

  2024cites this paper
• MSCPT: Few-Shot Whole Slide Image Classification With Multi-Scale and Context-Focused Prompt Tuning

  2024cites this paper
• Multi-Scale Heterogeneity-Aware Hypergraph Representation for Histopathology Whole Slide Images

  2024cites this paper
• Targeted FT-NIR and SERS Detection of Breast Cancer HER-II Biomarkers in Blood Serum Using PCB-Based Plasmonic Active Nanostructured Thin Film Label-Free Immunosensor Immobilized with Directional GNU-Conjugated Antibody

  2024cites this paper
• Quenching study of Cu2S-MPA/NGODs composites in electrochemiluminescence detection by modulating resonance energy transfer and adsorption process.

  2024cites this paper
• Nanomaterial-based electrochemical biosensors as tools for detecting the tumor biomarker miR-21.

  2024cites this paper
• Performance evaluation and characterization of pre-analytical effects by sample types and storage conditions on tumor marker measurement by the point-of-care test platform IchromaTM II.

  2024cites this paper
• Potentialities of Bio-functionalized Carbon Nanotubes for Different Anti-cancerous Activities

  2024cites this paper
• DNA‐Programmed (De)Hybridization of Near‐Infrared Photosensitized UCNP‐QDs‐GNPs Nanoprobes for MicroRNA Imaging and Image‐Guided Cancer Therapy

  2024cites this paper
• Unlocking the potential of oncology biomarkers: advancements in clinical theranostics

  2024cites this paper
• Ultrasensitive prostate cancer marker PCA3 detection with impedimetric biosensor based on specific label-free aptamers

  2024cites this paper
• Functional information guided adaptive radiation therapy

  2024cites this paper
• Collard-like Bi2S3@Au nanocomposites-based label free electrochemical immunosensor for quantitative detection of CA19-9.

  2024cites this paper
• Integration of pathologic characteristics, genetic risk and lifestyle exposure for colorectal cancer survival assessment

  2024cites this paper
• Biomarker-driven molecular imaging probes in radiotherapy

  2024cites this paper
• Integrated "lab-on-a-chip" microfluidic systems for isolation, enrichment, and analysis of cancer biomarkers.

  2023cites this paper
• Relationship between circulating tumour DNA and skeletal muscle stores at diagnosis of pancreatic ductal adenocarcinoma: a cross-sectional study

  2023cites this paper
• Electrochemical Biosensors for Whole Blood Analysis: Recent Progress, Challenges, and Future Perspectives.

  2023cites this paper
• Systematic and Comprehensive Analysis of tRNA-Derived Small RNAs Reveals Their Potential Regulatory Roles and Clinical Relevance in Sarcoidosis

  2023cites this paper
• High-plex immunofluorescence imaging and traditional histology of the same tissue section for discovering image-based biomarkers

  2023cites this paper
• Pre-analytical stability of the CEA, CYFRA 21.1, NSE, CA125 and HE4 tumor markers.

  2023cites this paper
• Application of nanoplasmonic biosensors based on nanoarrays in biological and chemical detection.

  2023cites this paper
• ADAR1 is a prognostic biomarker and is correlated with immune infiltration in lung adenocarcinoma

  2023cites this paper
• Localization of multiple DNAzymes as a branchedzyme-powered nanodevice for the immunoassay of tumor biomarkers.

  2023cites this paper
• Medical diagnostic value of digital PCR (dPCR): A systematic review

  2023cites this paper
• Surface Plasmon Resonance (SPR) Sensor for Cancer Biomarker Detection

  2023cites this paper
• Beyond glyco-proteomics-Understanding the role of genetics in cancer biomarkers.

  2023cites this paper
• Recent Trends in Biosensing and Diagnostic Methods for Novel Cancer Biomarkers

  2023cites this paper
• Artificial Intelligence Aids in Development of Nanomedicines for Cancer Management.

  2023cites this paper
• ULBP2 is a biomarker related to prognosis and immunity in colon cancer

  2023cites this paper
• Electrochemical ELASA: improving early cancer detection and monitoring

  2023cites this paper
• The Applications of 2D Materials for Electrochemical Biosensing, Drug Delivery, and Environmental Monitoring.

  2023cites this paper
• Recent progress in aptamer-based microfluidics for the detection of circulating tumor cells and extracellular vesicles

  2023cites this paper
• Mass spectrometry based biomarkers for early detection of HCC using a glycoproteomic approach.

  2023cites this paper
• Deep learning supported discovery of biomarkers for clinical prognosis of liver cancer

  2023cites this paper
• The issues and challenges with cancer biomarkers

  2023cites this paper
• Multi-modal digital pathology for colorectal cancer diagnosis by high-plex immunofluorescence imaging and traditional histology of the same tissue section

  2023cites this paper
• Predictive value of inflammatory markers in gastric cancer

  2023cites this paper
• Biomarkers for Cancer: A Detail Review

  2023cites this paper
• DNA tetrahedral nanostructures for the biomedical application and spatial orientation of biomolecules

  2023cites this paper
• Urinary VOCs as biomarkers of early stage lung tumour development in mice

  2023cites this paper